Stem cell transplantation for severe sclerosis associated with improved long-term survival

Among patients with a severe, life-threatening type of sclerosis, treatment with hematopoietic stem cell transplantation (HSCT), compared to intravenous infusion of the chemotherapeutic drug cyclophosphamide, was associated with an increased treatment-related risk of death in the first year, but…

Source: Stem cell transplantation for severe sclerosis associated with improved long-term survival